Free Access
Med Sci (Paris)
Volume 28, Number 10, Octobre 2012
Page(s) 805 - 809
Section Nouvelles
Published online 12 October 2012
  1. Northcott PA, Korshunov A, Witt H, et al. Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011 ; 29 : 1408–1414. [CrossRef] [PubMed] [Google Scholar]
  2. Yang ZJ, Ellis T, Markant SL, et al. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 2008 ; 14 : 135–145. [CrossRef] [PubMed] [Google Scholar]
  3. Schüller U, Heine VM, Mao J. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell 2008 ; 14 : 123–134. [CrossRef] [PubMed] [Google Scholar]
  4. Rausch T, Jones DT, Zapatka M, et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 2012 ; 148 : 59–71. [CrossRef] [PubMed] [Google Scholar]
  5. Reynaud C, Billaud M. La théorie de l’équilibre ponctuée : un bond en avant dans la compréhension du cancer. Med Sci (Paris) 2011 ; 27 : 921–923. [Google Scholar]
  6. Gibson P, Tong Y, Robinson G, et al. Subtypes of medulloblastoma have distinct developmental origins. Nature 2010 ; 468 : 1095–1099. [CrossRef] [PubMed] [Google Scholar]
  7. Pfaff E, Remke M, Sturm D, et al. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. J Clin Oncol 2010 ; 28 : 5188–5196. [CrossRef] [PubMed] [Google Scholar]
  8. Pei Y, Moore CE, Wang J, et al. An animal model of MYC-driven medulloblastoma. Cancer Cell 2012 ; 21 : 155–167. [CrossRef] [PubMed] [Google Scholar]
  9. Kawauchi D, Robinson G, Uziel T, et al. A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell 2012 ; 21 : 168–180. [CrossRef] [PubMed] [Google Scholar]
  10. Northcott PA, Nakahara Y, Wu X, et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 2009 ; 41 : 465–472. [CrossRef] [PubMed] [Google Scholar]
  11. Parsons DW, Li M, Zhang X, et al. The genetic landscape of the childhood cancer medulloblastoma. Science 2011 ; 331 : 435–439. [CrossRef] [PubMed] [Google Scholar]
  12. Wu X, Northcott PA, Dubuc A, et al. Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 2012 ; 482 : 529–533. [CrossRef] [PubMed] [Google Scholar]
  13. Baud O, Gressens P. Voie de signalisation Sonic Hedgehog et impact des glucocorticoïdes sur le cerveau en développement. Med Sci (Paris) 2009 ; 25 : 713–718. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  14. Ruat M, Angot E, Traiffort E. Sonic Hedgehog, un morphogène en quête de fonction dans le cerveau adulte. Med Sci (Paris) 2011 ; 27 : 979–985. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  15. Vidal V. Les inhibiteurs de la voie Hedgehog : un espoir pour le traitement des carcinomes basocellulaires. Med Sci (Paris) 2010 ; 26 : 231–233. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.